EUVIMEDEUVIMED entdecken
Multizentrische StudieLeserbrief

Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study

Yu Lan, Xiaoyan Wu, Linya Ni, Yuhua Liu, Tianmeng Yan, Dejian Duan, Zhenying Zhang

American Journal of Clinical Dermatology · 2024

DOI: 10.1007/s40257-024-00873-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Clinical Dermatology, 2024. Verfasst von Yu Lan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Eighth Affiliated Hospital, Sun Yat-Sen University, 3025 Shennan Road Central, Shenzhen, 518033, China. Hauptthemen laut MEDLINE: Psoriasis, Interleukin-17, Dermatitis, Exfoliative. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Shenzhen Innovation and Technology Commission Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisInterleukin-17Dermatitis, ExfoliativeHumansRetrospective StudiesMaleFemaleTreatment OutcomeMiddle AgedAdultAntibodies, Monoclonal, HumanizedDermatologic AgentsAgedSeverity of Illness IndexAdalimumab

Substanzen

Interleukin-17Antibodies, Monoclonal, HumanizedixekizumabsecukinumabDermatologic AgentsIL17A protein, humanAdalimumab

Autor:innen und Institutionen

  • Department of Dermatology, The Eighth Affiliated Hospital, Sun Yat-Sen University, 3025 Shennan Road Central, Shenzhen, 518033, China.
  • Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Haiyuan 1st Road, Shenzhen, 518040, China.
  • Department of Dermatology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 25 Yu'an 2nd Road, 30 District, Baoan District, Shenzhen, 518133, China.
  • Department of Dermatology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, 25 Yu'an 2nd Road, 30 District, Baoan District, Shenzhen, 518133, China. oldduan2000@163.com.
  • Department of Dermatology, The Eighth Affiliated Hospital, Sun Yat-Sen University, 3025 Shennan Road Central, Shenzhen, 518033, China. zhangzy@hku-szh.org.
  • Department of Dermatology, The University of Hong Kong-Shenzhen Hospital, Haiyuan 1st Road, Shenzhen, 518040, China. zhangzy@hku-szh.org.

Förderung

  • Shenzhen Innovation and Technology Commission Foundation

Zitieren

APA

Lan, Y., Wu, X., Ni, L., Liu, Y., Yan, T., Duan, D., & Zhang, Z. (2024). Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study. American Journal of Clinical Dermatology. https://doi.org/10.1007/s40257-024-00873-0

Vancouver

Lan Y, Wu X, Ni L, Liu Y, Yan T, Duan D, et al. Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study. American Journal of Clinical Dermatology. 2024. doi:10.1007/s40257-024-00873-0

BibTeX
@article{Lan2024,
  author = {Lan, Yu and Wu, Xiaoyan and Ni, Linya and Liu, Yuhua and Yan, Tianmeng and Duan, Dejian and Zhang, Zhenying},
  title = {Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study},
  journal = {American Journal of Clinical Dermatology},
  year = {2024},
  doi = {10.1007/s40257-024-00873-0}
}
Kostenlos starten →